loading...| Preferred Name |
Neostigmine |
|
| Synonyms |
Methylsulfate, Neostigmine |
|
| Definitions |
A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D009388 |
|
| altLabel |
Methylsulfate, Neostigmine Proserine Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl- Prostigmine Polstigmine Synstigmin Neostigmine Bromide Neostigmine Methylsulfate Bromide, Neostigmine Syntostigmine Prostigmin Prozerin |
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
| cui |
C0282261 C0027680 C0878189 C0032399 C0027679 C0039124 |
|
| DC |
1 |
|
| definition |
A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. |
|
| DX |
19660101 |
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
98IMH7M386 3982TWQ96G 005SYP50G5 0 |
|
| isa | ||
| LT |
TRD |
|
| Mapped from |
http://purl.bioontology.org/ontology/MESH/C065878 |
|
| MDA |
19990101 |
|
| MMR |
20130708 |
|
| MN |
D02.092.877.674.666 D02.675.276.602 |
|
| notation |
D009388 |
|
| PA |
D010277 D002800 |
|
| prefLabel |
Neostigmine |
|
| RR |
98IMH7M386 114-80-7 (bromide) 005SYP50G5 59-99-4 (Neostigmine) 51-60-5 (methyl sulfate) |
|
| TERMUI |
T028010 T028016 T028015 T028017 T028013 T028014 T028011 T028009 T028018 T028012 |
|
| TH |
FDA SRS (2014) UNK (19XX) INN (19XX) USP (19XX) BAN (19XX) |
|
| tui |
T109 T121 |
|
| subClassOf |